HEPATOCELLULAR CARCINOMA [neop]    
resection [topp]    
ABLATION [topp]    
Storm NOS [inpo]    
Phase 3 [tmco]    
DOUBLE BLIND [resa]    
placebo-controlled [resa]    
Trial [resa]    
Standard [qlco]    
Care [acty]    
Adjuvant Therapy [topp]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Trial [resa]    
Design [acty]    
Efficacy [qlco]    
Safety [hcpp]    
Placebo [topp]    
Adjuvant Therapy [topp]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
surgical resection [topp]    
LOCAL [spco]    
ABLATION [topp]    
Methods [inpr]    
Phase 3 [tmco]    
DOUBLE BLIND [resa]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Complete Response [fndg]    
Radiology [bmod]    
surgical resection [topp]    
LOCAL [spco]    
ABLATION [topp]    
Sites [spco]    
Research [resa]    
centres [spco]    
Countries [geoa]    
Patients [podg]    
Assigned [ftcn]    
Receive [qlco]    
MG [geoa]    
Oral [spco]    
Placebo [topp]    
Twice [inpr]    
Maximum [qnco]    
YEARS [tmco]    
Block [patf]    
Randomization [resa]    
Scheme [inpr]    
Block [patf]    
Size [spco]    
Interactive [ftcn]    
Vocal system [bdsy]    
Response [orga]    
Patients [podg]    
Stratified [qlco]    
Curative treatment [fndg]    
Geography [ocdi]    
Child-Pugh [inpr]    
Status [qlco]    
Recurrence Risk [qnco]    
Primary [qlco]    
Recurrence free survival [fndg]    
Assessed [acty]    
data base [inpr]    
Cutoff [ftcn]    
NoV [virs]    
Efficacy [qlco]    
Intention [menp]    
Safety [hcpp]    
Assigned [ftcn]    
Patients [podg]    
Receive [qlco]    
Study [mnob]    
DOSE [qnco]    
Final [qlco]    
Reported [inpr]    
Study [mnob]    
Registered [hlca]    
GOV [gngm]    
findings [ftcn]    
screen [hlca]    
Patients [podg]    
Aug. [fndg]    
NoV [virs]    
Assigned [ftcn]    
Patients [podg]    
Patients [podg]    
Group [idcn]    
RECEIVED [qlco]    
Study [mnob]    
treatment [ftcn]    
terminated [idcn]    
treatment [ftcn]    
Patients [podg]    
Placebo [topp]    
Group [idcn]    
RECEIVED [qlco]    
Study [mnob]    
treatment [ftcn]    
terminated [idcn]    
treatment [ftcn]    
Median [spco]    
Duration [tmco]    
treatment [ftcn]    
Daily Dose [qnco]    
MG [geoa]    
SD [mamm]    
Compared [acty]    
MG [geoa]    
Placebo [topp]    
DOSE MODIFICATION [resa]    
Reported [inpr]    
Patients [podg]    
Group [idcn]    
Patients [podg]    
Placebo [topp]    
Group [idcn]    
Final [qlco]    
Recurrence free survival [fndg]    
Events [evnt]    
Occurred [acty]    
Placebo [topp]    
Group [idcn]    
Group [idcn]    
Median [spco]    
Recurrence free survival [fndg]    
Group [idcn]    
2-19 [gngm]    
Placebo [topp]    
Group [idcn]    
Note [clna]    
Median [spco]    
Recurrence free survival [fndg]    
Groups [idcn]    
Group [idcn]    
Placebo [topp]    
Group P [inpr]    
Hazard Ratio [qnco]    
CI [geoa]    
One-sided [spco]    
Grade III [qlco]    
adverse events [patf]    
Hand Skin [bpoc]    
FOOT [bpoc]    
Reaction [ftcn]    
Patients [podg]    
Group [idcn]    
Patients [podg]    
Placebo [topp]    
Group [idcn]    
DIARRHOEA [sosy]    
Five [qnco]    
Placebo [topp]    
Group [idcn]    
Related [qlco]    
Serious Adverse Event [fndg]    
included [ftcn]    
Hand Skin [bpoc]    
FOOT [bpoc]    
Reaction [ftcn]    
TEN [dsyn]    
Abnormal hepatic function [patf]    
FATIGUE [sosy]    
Drug [phsu]    
relative death [fndg]    
Group [idcn]    
Placebo [topp]    
Group [idcn]    
INTERPRETATION [inpr]    
effective [qlco]    
intervention [hlca]    
Setting [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Following [tmco]    
resection [topp]    
ABLATION [topp]    
